Deep Learning and Cardiovascular Risk Factors

Lily, could you give us a summary of the key take aways that you learned from your experience there? I think the main findings from that study was that the AI performed well in these populations likely due to all the other validation that was done before it. And I think we found some interesting bottlenecks in the workflow to then inform a larger study and inform the national deployment. Another piece I think that's interesting from studies like that is to understand the potential inputs into cost effectiveness models or whatnot if you're trying to model cost effectiveness.